Similarly, in lung cancer, high expression of KRT17 is not associated with OS in LUSC (Wang et al., 2019), while in LUAD, high expression of KRT17 is associated with survival (Liu et al., 2018), indicating that the expression status and clinical prognosis implications of KRT17 may be related to pathological classification. Here, KRT17 is linked to lung cancer.